LIVIVO - Search results -

Search results

Result 1 - 10 of total 63

Search options

Article: [guidelines for HIV testing in Poland].

Janczarek, Małgorzata Łucja / Grzeszczuk, Anna

Wiadomosci lekarskie (Warsaw, Poland : 1960)

2017 Volume 70, Issue 2 pt 2, Page(s) 395–398

Abstract: Including HIV disease in the differential diagnosis is the responsibility of the treating physician. Unfortunately, despite 35 years passed from the description of the first cases of Acquired Immune Deficiency Syndrome, AIDS testing for HIV is offered ... ...

Abstract	Including HIV disease in the differential diagnosis is the responsibility of the treating physician. Unfortunately, despite 35 years passed from the description of the first cases of Acquired Immune Deficiency Syndrome, AIDS testing for HIV is offered sporadically in Poland. The aim of this paper is to present the current recommendations for HIV testing.
MeSH term(s)	Acquired Immunodeficiency Syndrome/diagnosis ; HIV ; HIV Infections/diagnosis ; Humans ; Poland ; Practice Guidelines as Topic
Language	Polish
Publishing date	2017-10-18
Publishing country	Poland
Document type	Journal Article
ZDB-ID	414731-5
ISSN	0043-5147 ; 1895-0485 ; 0860-8865
ISSN	0043-5147 ; 1895-0485 ; 0860-8865
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 646: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Details ▾
- See ZB MED holdings
- Order with fees

Article: Effects of Pegylated Interferon Alpha and Ribavirin (pegIFN-α/RBV) Therapeutic Approach on Regulatory T Cells in HCV-Monoinfected and HCV/HIV-Coinfected Patients

Grubczak, Kamil / Grzeszczuk, Anna / Groth, Monika / Hryniewicz, Anna / Kretowska-Grunwald, Anna / Flisiak, Robert / Moniuszko, Marcin

Viruses. 2021 July 25, v. 13, no. 8

2021

Abstract: Approximately 25% of HIV-infected patients are co-infected with HCV. Notably, the burden of HCV infection (e.g., viral persistence, viral load, or HCV-related liver symptoms) is more pronounced in the presence of HIV co-infection. However, to date, the ... ...

Abstract	Approximately 25% of HIV-infected patients are co-infected with HCV. Notably, the burden of HCV infection (e.g., viral persistence, viral load, or HCV-related liver symptoms) is more pronounced in the presence of HIV co-infection. However, to date, the underlying immune mechanisms accounting for accelerated disease progression in HIV/HCV-coinfected individuals have not been described in sufficient detail. We hypothesized that regulatory T cells (Treg) bearing potent immunosuppressive capacities could not only play a substantial role in the pathogenesis of HCV/HIV coinfection but also modulate the response to the standard anti-viral therapy. Materials and Methods: To this end, we studied alterations in frequencies of Treg cells in correlation with other Treg-related and virus-related parameters in both HCV and HCV/HIV-infected patients subjected to standard pegIFN-α/RBV therapy. Results: Notably, we found that pegIFN-α/RBV therapy significantly increased levels of Treg cells in HCV-infected but not in HIV/HCV-coinfected individuals. Furthermore, HIV/HCV-coinfection was demonstrated to inhibit expansion of regulatory T cells during anti-viral treatment; thus, it might probably be responsible for viral persistence and HCV-related liver damage. Conclusions: Therapy with pegIFN-α/RBV demonstrated a significant effect on regulatory T cells in the course of HIV and/or HCV infection indicating a crucial role in the anti-viral immune response.
Keywords	HIV infections ; disease progression ; immune response ; immunosuppression ; interferons ; liver ; mixed infection ; pathogenesis ; therapeutics ; viral load
Language	English
Dates of publication	2021-0725
Publishing place	Multidisciplinary Digital Publishing Institute
Document type	Article
ZDB-ID	2516098-9
ISSN	1999-4915
ISSN	1999-4915
DOI	10.3390/v13081448
Database	NAL-Catalogue (AGRICOLA)

Order via subito

Book: Borelioza w praktyce klinicznej

Grzeszczuk, Anna

2010

Author's details	dr hab. n. med. Anna Grzeszczuk
MeSH term(s)	Lyme Disease
Language	Polish
Size	61 pages :, illustrations
Edition	Wydanie I (dodruk).
Document type	Book
ISBN	9788320042092 ; 8320042097
Database	Catalogue of the US National Library of Medicine (NLM)

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article: Translokacja bakteryjna w zakazeniu HIV.

Oleksiuk, Jolanta / Grzeszczuk, Anna

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego

2014 Volume 37, Issue 222, Page(s) 353–355

Abstract: Contemporary antiretroviral therapy has significantly improved the prognosis of human immunodeficiency virus (HIV) infected individuals. However, treated individuals manifest increased mortality, compared to general population. This increased mortality ... ...

Title translation	Microbial translocation in HIV infection.
Abstract	Contemporary antiretroviral therapy has significantly improved the prognosis of human immunodeficiency virus (HIV) infected individuals. However, treated individuals manifest increased mortality, compared to general population. This increased mortality seems to be associated with chronic immune activation which persist despite decrease of plasma HIV viremia levels. Recently, translocation of bacterial products from the gastrointestinal tract has been proposed as a major cause of pathological immune activation.
MeSH term(s)	Antiretroviral Therapy, Highly Active ; Bacterial Translocation/immunology ; HIV Infections/drug therapy ; HIV Infections/immunology ; HIV Infections/virology ; Humans ; Lymphocyte Activation/immunology ; Viral Load
Language	Polish
Publishing date	2014-12
Publishing country	Poland
Document type	English Abstract ; Journal Article ; Review
ZDB-ID	1388406-2
ISSN	1426-9686
ISSN	1426-9686
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 4780: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Effects of Pegylated Interferon Alpha and Ribavirin (pegIFN-α/RBV) Therapeutic Approach on Regulatory T Cells in HCV-Monoinfected and HCV/HIV-Coinfected Patients.

Grubczak, Kamil / Grzeszczuk, Anna / Groth, Monika / Hryniewicz, Anna / Kretowska-Grunwald, Anna / Flisiak, Robert / Moniuszko, Marcin

Viruses

2021 Volume 13, Issue 8

Abstract	Approximately 25% of HIV-infected patients are co-infected with HCV. Notably, the burden of HCV infection (e.g., viral persistence, viral load, or HCV-related liver symptoms) is more pronounced in the presence of HIV co-infection. However, to date, the underlying immune mechanisms accounting for accelerated disease progression in HIV/HCV-coinfected individuals have not been described in sufficient detail. We hypothesized that regulatory T cells (Treg) bearing potent immunosuppressive capacities could not only play a substantial role in the pathogenesis of HCV/HIV coinfection but also modulate the response to the standard anti-viral therapy. Materials and methods: To this end, we studied alterations in frequencies of Treg cells in correlation with other Treg-related and virus-related parameters in both HCV and HCV/HIV-infected patients subjected to standard pegIFN-α/RBV therapy. Results: Notably, we found that pegIFN-α/RBV therapy significantly increased levels of Treg cells in HCV-infected but not in HIV/HCV-coinfected individuals. Furthermore, HIV/HCV-coinfection was demonstrated to inhibit expansion of regulatory T cells during anti-viral treatment; thus, it might probably be responsible for viral persistence and HCV-related liver damage. Conclusions: Therapy with pegIFN-α/RBV demonstrated a significant effect on regulatory T cells in the course of HIV and/or HCV infection indicating a crucial role in the anti-viral immune response.
MeSH term(s)	Antiviral Agents/therapeutic use ; Drug Therapy, Combination ; Female ; Genotype ; HIV/drug effects ; HIV/immunology ; HIV Infections/drug therapy ; HIV Infections/immunology ; HIV Infections/virology ; Hepacivirus/drug effects ; Hepacivirus/genetics ; Hepacivirus/immunology ; Hepatitis C/drug therapy ; Hepatitis C/immunology ; Humans ; Immune Tolerance/drug effects ; Interferon-alpha/therapeutic use ; Male ; Polyethylene Glycols/therapeutic use ; Recombinant Proteins/therapeutic use ; Ribavirin/therapeutic use ; T-Lymphocytes, Regulatory/immunology ; Viral Load/drug effects
Chemical Substances	Antiviral Agents ; Interferon-alpha ; Recombinant Proteins ; Polyethylene Glycols (3WJQ0SDW1A) ; Ribavirin (49717AWG6K) ; peginterferon alfa-2a (Q46947FE7K)
Language	English
Publishing date	2021-07-25
Publishing country	Switzerland
Document type	Journal Article
ZDB-ID	2516098-9
ISSN	1999-4915 ; 1999-4915
ISSN (online)	1999-4915
ISSN	1999-4915
DOI	10.3390/v13081448
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Metabolic syndrome in HIV infected adults in Poland.

Rogalska-Płońska, Magdalena / Grzeszczuk, Anna / Rogalski, Paweł / Łucejko, Mariusz / Flisiak, Robert

Kardiologia polska

2018 Volume 76, Issue 3, Page(s) 548–553

Abstract: Background: Metabolic syndrome (MS) is usually diagnosed based on the presence of abdominal obesity, elevated blood pres-sure (BP), elevated fasting plasma glucose, high serum triglycerides (TG), and low high-density lipoprotein (HDL) cholesterol levels. ...

Abstract	Background: Metabolic syndrome (MS) is usually diagnosed based on the presence of abdominal obesity, elevated blood pres-sure (BP), elevated fasting plasma glucose, high serum triglycerides (TG), and low high-density lipoprotein (HDL) cholesterol levels. Whether HIV is associated with a higher prevalence of MS than in the general population remains unclear. Aim: The aim of the study was to determine the incidence of MS in the population of HIV-infected adults and its association with clinical, virological, and biochemical features. Methods: Two hundred and seventy HIV-infected Caucasian adult patients were enrolled in the study and evaluated based on clinical records in the years 2013-2015. Results: Metabolic syndrome was diagnosed in 60 of 270 (22%) patients, 47 (24%) males and 13 (17%) females, mostly (72%) aged above 40 years. The percentage of patients with diagnosed MS in specific age groups in comparison to the general Polish population for females aged < 40 years was 7% vs. 4%, and males in the same age - 18% vs. 9%, for females aged 40-59 years - 47% vs. 24.4%, and males - 33% vs. 28.3%. Particular components of MS in the MS population were found as follows: body mass index > 30 kg/m2 in 29%, waist circumference exceeding 94 cm in men and 80 cm in woman - 87.5%, TG ≥ 150 mg/dL - 82%, HDL cholesterol < 40/50 mg/dL (males/females) - 42%, systolic/diastolic BP ≥ 130 mmHg/≥ 85 mmHg - 83%, and fasting glucose > 100 mg/dL - 42%. In stepwise multivariate logistic regression analysis, age (odds ratio [OR] 1.052, 95% con-fidence interval [CI] 1.018-1.088, p = 0.003) and nadir CD4 < 350 cells/mm3 (OR 3.576, 95% CI 1.035-12.355, p = 0.04) were associated with MS. Patients with MS compared with those without this disorder had low, intermediate, high, and very high cardiovascular risk in 10% vs. 23%, 73% vs. 70%, 7% vs. 5%, and 10% vs. 2%, respectively (p = 0.006). Conclusions: Prevalence of MS in the HIV-infected population is higher than in the general Polish population. Age and low nadir CD4 were found to be associated with MS.
MeSH term(s)	Adolescent ; Adult ; Female ; HIV Infections/complications ; Humans ; Male ; Metabolic Syndrome/complications ; Metabolic Syndrome/epidemiology ; Middle Aged ; Poland/epidemiology ; Prevalence ; Young Adult
Language	English
Publishing date	2018-01-19
Publishing country	Poland
Document type	Journal Article
ZDB-ID	411492-9
ISSN	1897-4279 ; 0022-9032
ISSN (online)	1897-4279
ISSN	0022-9032
DOI	10.5603/KP.a2017.0249
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.B 598: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG)
Zs.MO 474: Show issues

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: The justification for the early introduction of antiretroviral therapy in patients living with HIV.

Kozłowski, Paweł / Grzeszczuk, Anna / Flisiak, Robert

Przeglad epidemiologiczny

2014 Volume 68, Issue 1, Page(s) 5–9, 101–4

Abstract: In the last years the retroviral disease, caused by the human immunodeficiency virus (HIV), turned from an incurable to a chronic disease. This fundamental change happened due to a huge progress in the understanding of the pathogenesis and treatment of ... ...

Abstract	In the last years the retroviral disease, caused by the human immunodeficiency virus (HIV), turned from an incurable to a chronic disease. This fundamental change happened due to a huge progress in the understanding of the pathogenesis and treatment of this infection. However, one question still remains open: what is the best time to introduce therapy. The CD4 count is the point of reference to start of the treatment in HIV infected patients. Tendency to introduce highly active antiretroviral therapy (HAART) as early as possible has been observed recently. According to the most recent guidelines of the World Health Organization HAART should be started when CD4 reaches < or = 500 cells/microl. The aim of this paper is justification for the early introduction of antiretroviral therapy in patients living with HIV.
MeSH term(s)	Adult ; Aged ; Aged, 80 and over ; Antiretroviral Therapy, Highly Active ; Antiviral Agents/administration & dosage ; CD4 Lymphocyte Count ; Female ; Guidelines as Topic ; HIV Infections/drug therapy ; HIV Infections/immunology ; HIV-1/drug effects ; Humans ; Male ; Middle Aged ; Poland ; Secondary Prevention ; Young Adult
Chemical Substances	Antiviral Agents
Language	Polish
Publishing date	2014
Publishing country	Poland
Document type	Journal Article
ZDB-ID	421782-2
ISSN	0033-2100
ISSN	0033-2100
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.B 639: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: Późne rozpoznanie choroby retrowirusowej, mimo wielokrotnych hospitalizacji--opis przypadku.

Szulzyk, Tomasz / Bekiesz, Wojciech / Grzeszczuk, Anna / Flisiak, Robert

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego

2014 Volume 36, Issue 213, Page(s) 200–202

Abstract: Prevalence of human immunodeficiency virus (HIV) infection remains very low in Poland and is estimated to be 0.2%. The number of people undergoing HIV-testing is low. Only 10% population was ever tested and the HIV morbidity increases yearly in Poland. ... ...

Title translation	Delayed HIV disease diagnosis, despite multiple hospitalizations--case report.
Abstract	Prevalence of human immunodeficiency virus (HIV) infection remains very low in Poland and is estimated to be 0.2%. The number of people undergoing HIV-testing is low. Only 10% population was ever tested and the HIV morbidity increases yearly in Poland. The percentage of late diagnoses is high and remains so in recent years. The aim of the current paper was to present a case of female patient, the partner intravenous drug user, who was hospitalized several times due to: aseptic meningitis, delivery, thrombocytopenia and was never offered a HIV testing. The disease was diagnosed at the late stage with CD4 count of 39 cells/microl (13%). Diagnosis of the disease at the advanced stage potentially reduces a chance for successful treatment and is associated with worse prognosis. Routine testing for HIV infection should be widely available in any health care facility and be directed in particular to people with specific indicator conditions or risky behaviors.
MeSH term(s)	Adult ; CD4 Lymphocyte Count ; Delayed Diagnosis ; Diagnosis, Differential ; Female ; HIV Infections/blood ; HIV Infections/diagnosis ; Humans ; Meningitis, Aseptic/diagnosis ; Prognosis ; Thrombocytopenia/diagnosis
Language	Polish
Publishing date	2014-03
Publishing country	Poland
Document type	Case Reports ; English Abstract ; Journal Article
ZDB-ID	1388406-2
ISSN	1426-9686
ISSN	1426-9686
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 4780: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: Prevalence and Risk Factors of HCV/HIV Co-Infection and HCV Genotype Distribution in North-Eastern Poland.

Grzeszczuk, Anna / Wandalowicz, Alicja Danuta / Jaroszewicz, Jerzy / Flisiak, Robert

Hepatitis monthly

2015 Volume 15, Issue 7, Page(s) e27740

Abstract: Background: HIV/HCV co-infection predisposes to accelerated liver damage and increased both liver-related and unrelated morbidity and mortality in patients with HIV infection.: Objectives: The aim of this study was to evaluate the prevalence of HCV ... ...

Abstract	Background: HIV/HCV co-infection predisposes to accelerated liver damage and increased both liver-related and unrelated morbidity and mortality in patients with HIV infection. Objectives: The aim of this study was to evaluate the prevalence of HCV infection, seropositivity, risk factors and genotype distribution among treated HIV positive patients. Furthermore, the occurrence and causes of deaths were analyzed. Patients and methods: Adult HIV-1 infected patients, with at least one antiHCV result, treated in one of Polish HIV/AIDS reference centers, participated in this cross-sectional study. Results: Four hundred and fifty seven patients with a median age of 38 years (ranged 23 - 72), and predominantly male (76.6%) were enrolled in the study. Anti-HCV antibodies were detected in 325 individuals (71.1%). HCV RNA was detected in 207 of the 233 patients tested (88%). The HCV genotype analysis (n = 193) demonstrated almost equal distribution with slight genotype 1 domination as 37.3%, mainly 1b, followed by genotypes 3 as 32.1% and 4 as 30.6%. No association was found between HCV genotype and route of HIV acquisition. In univariate analysis, higher HCV seropositivity was related to male sex, intravenous drug use (IDU), mode of HIV transmission, history of drug and alcohol abuse and imprisonment. In multivariate analysis, only being injection drug user (P = 0.0001), imprisonment (P = 0.310) and younger age at the HIV diagnosis per each year (P = 0.025) were identified as risk factors for HCV infection. Sixty three deaths were reported; no association was found between HCV seropositivity and death prevalence. Conclusions: HIV/HCV co-infection is an important medical problem in North-Eastern Poland. A history of incarceration and younger age at HIV diagnosis were additional to IDU risk factors for HCV seropositivity in this cohort.
Language	English
Publishing date	2015-07-22
Publishing country	Iran
Document type	Journal Article
ZDB-ID	2236753-6
ISSN	1735-3408 ; 1735-143X
ISSN (online)	1735-3408
ISSN	1735-143X
DOI	10.5812/hepatmon.27740v2
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article: Stezenie antygenu rdzeniowego HCV u chorych zakazonych HCV i współzakazonych HCV/HIV.

Łucejko, Mariusz / Grzeszczuk, Anna / Jaroszewicz, Jerzy / Flisiak, Robert

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego

2013 Volume 35, Issue 206, Page(s) 72–76

Abstract: Unlabelled: Currently, in the diagnosis and monitoring of treatment of HCV infection are used molecular biology methods to detect HCV genetic material and which are based on the polymerase chain reaction (PCR). Due to limitations in the application of ... ...

Title translation	Serum HCV core antigen concentration in HCV monoinfection and HCV/HIV coinfection.
Abstract	Unlabelled: Currently, in the diagnosis and monitoring of treatment of HCV infection are used molecular biology methods to detect HCV genetic material and which are based on the polymerase chain reaction (PCR). Due to limitations in the application of this method, such as expensiveness and labor intensive, the alternative might be quantification of HCV core antigen (HCVcAg). Aim of the study was an evaluation of HCVcAg concentrations in patients monoinfected with HCV and HCV/HIV coinfected depending on laboratory parameters characterizing HCV and HIV infections, as well as to evaluate the usefulness of HCVcAg concentrations as a predictor of treatment efficacy. Materials and methods: The study was conducted in 31 patients including 12 HCV/HIV coinfected and 19 HCV monoinfected enrolled for treatment with pegylated interferon combined with ribavirin. HCVcAg concentrations were analyzed with regard to HCV RNA level, laboratory indicators of liver function and hematology and additionally in HIV infected to HIV RNA level and immune status. During the treatment the prognostic value of HCVcAg concentrations were analyzed before treatment, at 24 hours, as well as 4 and 12 weeks after initiation of therapy for possible prediction of sustained virologic response (SVR). Results: Among HCV monoinfected patients significant correlation has been shown between HCVcAg concentrations and HCV RNA levels, that was not a case in HCV/HIV co-infection. Significant HCVcAg reduction was demonstrated in both groups during initial 24 hours of treatment, but there were no significant differences between groups at particular time points. Baseline HCVcAg levels were significantly higher in patients without SVR compared to those who achieved SVR and this trend continued throughout the analyzed treatment period. Conclusions: HCVcAg concentration demonstrate correlation with HCV RNA, and its decrease at the beginning of treatment can predict SVR. HIV coinfection does not affect HCVcAg concentration during therapy.
MeSH term(s)	Adult ; Coinfection/immunology ; Female ; HIV Infections/complications ; HIV Infections/drug therapy ; HIV Infections/immunology ; HIV Seropositivity/complications ; HIV Seropositivity/drug therapy ; HIV Seropositivity/immunology ; Hepacivirus/isolation & purification ; Hepatitis C Antigens/analysis ; Hepatitis C, Chronic/complications ; Hepatitis C, Chronic/immunology ; Humans ; Male ; RNA, Viral/isolation & purification ; Viral Load ; Young Adult
Chemical Substances	Hepatitis C Antigens ; RNA, Viral
Language	Polish
Publishing date	2013-08
Publishing country	Poland
Document type	English Abstract ; Journal Article
ZDB-ID	1388406-2
ISSN	1426-9686
ISSN	1426-9686
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 4780: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

To top

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito